SCHEMBL19828533

SCHEMBL19828533

C=CS(C)(C)N(c1ccc(N(S(C)(C)C=C)S(C)(C)C=C)cc1)S(C)(C)C=C

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19828343 0.91 ALDH1A1 (0.42) ALDH1A1TSHR
SCHEMBL21732139 0.87 ALDH1A1 (0.35) ALDH1A1ALOX15TSHR
SCHEMBL19828559 0.87 APLNR (0.46) ALDH1A1ALOX15TSHR
SCHEMBL22761812 0.70 ALDH1A1 (0.50) ALDH1A1TSHR
SCHEMBL22761605 0.65 ALDH1A1 (0.42) ALDH1A1TSHR
SCHEMBL21732226 0.63 — —
SCHEMBL22895281 0.61 — —
SCHEMBL19069989 0.59 TDP1 (0.37) ALDH1A1TSHRHSD17B10
SCHEMBL21732215 0.57 — —
SCHEMBL19828335 0.57 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10858377-B2 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers TRINSEO EUROPE GMBH (CH) 2020-12-08 — — US disclosed
US-20200055881-A1 MULTIVINYLAMINOSILANES AS BRANCHING AGENTS FOR FUNCTIONALIZED ELASTOMERIC POLYMERS TRINSEO EUROPE GMBH (CH) 2020-02-20 — — US disclosed
US-20180030070-A1 Multivinylaminosilanes as Branching Agents for Functionalized Elastomeric Polymers TRINSEO EUROPE GMBH (CH) 2018-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200055881-A1 MULTIVINYLAMINOSILANES AS BRANCHING AGENTS FOR FUNCTIONALIZED ELASTOMERIC POLYMERS PRUNE1, GNE, TERB1 ALDH1A1 2357/4885ALOX15 871/4885TSHR 2887/4885
US-20180030070-A1 Multivinylaminosilanes as Branching Agents for Functionalized Elastomeric Polymers GMNN, GNE, MSN ALDH1A1 2672/4885ALOX15 949/4885TSHR 2520/4885
US-10858377-B2 Multivinylaminosilanes as branching agents for functionalized elastomeric polymers GMNN, GNE, MSN ALDH1A1 2672/4885ALOX15 949/4885TSHR 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback